| Literature DB >> 24891615 |
Anjum Zafar1, Fan Wu1, Kristine Hardy1, Jasmine Li1, Wen Juan Tu1, Robert McCuaig1, Janelle Harris2, Kum Kum Khanna2, Joanne Attema3, Philip A Gregory3, Gregory J Goodall4, Kirsti Harrington5, Jane E Dahlstrom6, Tara Boulding1, Rebecca Madden1, Abel Tan1, Peter J Milburn7, Sudha Rao8.
Abstract
Epithelial to mesenchymal transition (EMT) is activated during cancer invasion and metastasis, enriches for cancer stem cells (CSCs), and contributes to therapeutic resistance and disease recurrence. Signal transduction kinases play a pivotal role as chromatin-anchored proteins in eukaryotes. Here we report for the first time that protein kinase C-theta (PKC-θ) promotes EMT by acting as a critical chromatin-anchored switch for inducible genes via transforming growth factor β (TGF-β) and the key inflammatory regulatory protein NF-κB. Chromatinized PKC-θ exists as an active transcription complex and is required to establish a permissive chromatin state at signature EMT genes. Genome-wide analysis identifies a unique cohort of inducible PKC-θ-sensitive genes that are directly tethered to PKC-θ in the mesenchymal state. Collectively, we show that cross talk between signaling kinases and chromatin is critical for eliciting inducible transcriptional programs that drive mesenchymal differentiation and CSC formation, providing novel mechanisms to target using epigenetic therapy in breast cancer.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24891615 PMCID: PMC4135602 DOI: 10.1128/MCB.01693-13
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272